13048_2019_562_MOESM3_ESM.docx (16.23 kB)

MOESM3 of Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study

journal contribution

posted on 2019-09-14, 03:51 authored by Yan Gao, Yuan Li, Chunyu Zhang, Jinsong Han, Huamao Liang, Kun Zhang, Hongyan Guo

Additional file 3: Table S3. Multivariate analysis of risk factors for platinum resistance recurrence after NACT-IDS and PDS. (DOCX 16 kb)

History

Usage metrics

Categories

Keywords

Advanced ovarian epithelial Cancer Neoadjuvant chemotherapy Primary Debulking surgery Chemoresistance Prognosis

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC